InfuSystem Inc.
INFU | AMEX
$13.11
+$0.31 (+2.42%)
Sep 22, 2026, 4:00 PM ET · Market open
Company Profile
InfuSystem Holdings, Inc. delivers infusion pumps, along with associated products and support services, to clients across the United States and Canada. The enterprise operates through two principal divisions: Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The ITS segment specializes in providing electronic ambulatory infusion devices and accompanying disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy facilities. These devices are crucial for managing various cancers, including colorectal cancer, as well as for pain management and other therapeutic needs. Moreover, the company markets, leases, and rents out a selection of new and pre-owned infusion pumps (both pole-mounted and ambulatory) and other vital durable medical equipment. It also sells consumables essential for treatment. InfuSystem further extends its offerings to include biomedical recertification, maintenance, and repair services for oncology practices and diverse alternative care settings, such as home care and home infusion providers, skilled nursing facilities, pain centers, and hospitals. Additionally, InfuSystem furnishes both local and field-based customer assistance and manages dedicated pump service and repair facilities. The company was founded in 2005 and maintains its corporate headquarters in Rochester Hills, Michigan.
Key Executives
| Name | Position |
|---|---|
| Carrie Lachance | President, Chief Executive Officer & Director |
| Addam Chupa | Executive Vice President & Chief Information Officer |
| Barry G. Steele | Executive Vice President & Chief Financial Officer |
| Jeanie Latz | Corporate Secretary |
| Jerod Funke | Executive Vice President & Chief HR Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 04, 2026 | 10-Q | Quarterly Report |
| Aug 04, 2026 | 8-K | Current Report |
| Aug 04, 2026 | 8-K | Current Report |
| Jul 28, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Jul 28, 2026 | 8-K | Current Report |
| May 19, 2026 | 4 | Filing |
| May 19, 2026 | 4 | Filing |
| May 19, 2026 | 4 | Filing |
| May 19, 2026 | 4 | Filing |
| May 18, 2026 | 8-K | Current Report |
InfuSystem Inc.
| Country | United States |
| IPO Date | Dec 26, 2007 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 467 |
| CEO | Carrie A. Lachance |
Contact Details
3851 West Hamlin Road Rochester Hills,
Michigan 48309 United States
Stock Details
| Ticker Symbol | INFU |
| Exchange | AMEX |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001337013 |
| CUSIP Number | 45685K102 |
| ISIN Number | US45685K1025 |
| SIC Code | 3841 |
Add to Watchlist
Select watchlists to add or remove INFU